Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic.
The COVID-19 pandemic forced us to rapidly and dramatically shift our medical priorities and decision making. With little literature or experience to rely on, the initial priority was to minimize patient exposure to the hospital and to others. It remains unclear whether cancer patients are at higher risk of infection or serious complications, or if it is our traditional therapies that place them to be at higher risk. By far, the greatest negative impact was on screening. Routine colonoscopies were considered elective, and as a result, delays in diagnosis will be felt for years to come. The most positive changes were the incorporation of tele-visits, increased use of oral therapies, alterations in treatment schedules of both chemotherapy and radiation, and an increased emphasis on neoadjuvant therapy. These too will be felt for years to come. The colorectal cancer medical community has responded collaboratively and effectively to maintain treatment and to optimize outcomes for our patients during the COVID-19 pandemic.
['Mukherji|Reetu|R|http://orcid.org/0000-0001-7384-0498', 'Marshall|John L|JL|']
D000086382:COVID-19 D003113:Colonoscopy D015179:Colorectal Neoplasms D019468:Disease Management D055088:Early Detection of Cancer D006801:Humans D000086402:SARS-CoV-2 D017216:Telemedicine
Colorectal cancer Cancer COVID-19 Pandemic Colon cancer Coronavirus Malignancy Rectal cancer